Research Awards and Information
Dr. Vladimir Badovinac received a notice of R21 multi-PI funding with Dr. John Harty (Microbiology) from the National Institutes of Health. The title of the project is Cellular intermediates in stable memory CD8 T cell maintenance. This award is for the period of February 1, 2012 through January 31, 2014. The amount of this award is $414,230.
Dr. Gary Baumbach received a notice of R01 funding from the National Institutes of Health. The title of the project is Cerebrovascular Structure in Hypertension: Mechanisms and Contributions to Stroke. This award is for the period of September 1, 2011 through July 31, 2016. The amount of this award is $1,651,563.
Dr. Daniel Diekema has a new research contract negotiated with Innovative Biosensors, Inc. for a research project titled Evaluation of the BioFlash-Dx System for Rapid Detection of Methicllin Resistant Staphylococcus aureus (MRSA). The contract total is $62,500. This contract is for the period of August 25, 2011 through August 25, 2013.
Dr. Daniel Diekema has a new research contract negotiated with Cerexa, Inc. for the continuation of a research project titled In Vitro Activity of Ceftaroline Versus Staphylococcus Aureus. The contract total is $609,500. This contract is for the period of August 4, 2011 through December 31, 2012.